News Alerts

27 Jun 2020 | 10:46 PM UTC

Peru: Government to lift most COVID-19 lockdown restrictions from July 1 /update 19

Peru News Alert

Authorities to end most COVID-19 lockdown restrictions as of July 1; follow government directives

TIMEFRAME expected from 6/27/2020, 10:00 PM until 7/31/2020, 11:59 PM (America/Lima). COUNTRY/REGION Peru

Read all related news alert(s):
06 Mar 03:35 PM UTC  — 

Peru: First COVID-19 case confirmed March 6


Peruvian authorities announced on Friday, June 26, that most lockdown restrictions introduced due to the coronavirus disease (COVID-19) pandemic will be lifted as of Wednesday, July 1, in most parts of the country, including Lima. The announcement comes despite the extension of the nationwide state of emergency until at least July 31. From Wednesday, supermarkets and banks will be allowed to reopen at a 50 percent capacity, enforcing a 1m (3.2ft) social distancing rule and the mandatory use of face masks. A nighttime curfew will be in effect between 22:00 and 04:00 (local time) and all-day Sunday curfews will be lifted. The curfew orders will remain in place for children under 14 and adults who are older than 65 or have underlying health issues, considered to be more at risk. The government is still considering whether to allow domestic land or air travel to resume; however, borders will remain closed for international travel. Authorities are also debating whether restaurants will be allowed to resume operations.

The abovementioned relaxation to lockdown rules will not apply for seven regions that have higher infection rates, including the Arequipa, Ica, Junín, Huánuco, San Martín, Madre de Dios, and Áncash regions. In these regions, the curfew will be in effect as of 20:00 until 04:00 and all-day Sunday curfews will continue.

As of Saturday, June 27, there have been 272,364 confirmed cases of COVID-19 in Peru, with 8939 associated fatalities. Further international spread of the virus is expected in the near term.


The first case of COVID-19 was reported on December 31 and the source of the outbreak has been linked to a wet market in Wuhan (Hubei province, China). Human-to-human and patient-to-medical staff transmission of the virus have been confirmed. Many of the associated fatalities have been due to pneumonia caused by the virus.

Cases of the virus have been confirmed in numerous countries and territories worldwide. Virus-screening and quarantining measures are being implemented at airports worldwide, as well as extensive travel restrictions. On March 11, the World Health Organization (WHO) declared COVID-19 a pandemic.

Pneumonia symptoms include dry cough, chest pain, fever, and labored breathing. Pneumonia can be contagious and can be transmitted from human to human. The influenza virus, or the flu, is a common cause of viral pneumonia.


Measures adopted by local authorities evolve quickly and are usually effective immediately. Depending on the evolution of the outbreak in other countries, authorities are likely to modify, at very short notice, the list of countries whose travelers are subject to border control measures or entry restrictions upon their arrival to the territory in question. It is advised to postpone nonessential travel due to the risk that travelers may be refused entry or be subject to quarantine upon their arrival or during their stay.

To reduce the risk of COVID-19 transmission, travelers are advised to abide by the following measures:

  • Frequently clean hands by applying an alcohol-based hand rub or washing with soap and water.
  • When coughing and sneezing, cover mouth and nose with a flexed elbow or tissue; if used, throw the tissue away immediately and wash hands.
  • If experiencing a fever, cough, difficulty breathing, or any other symptoms suggestive of respiratory illness, including pneumonia, call emergency services before going to the doctor or hospital to prevent the potential spread of the disease.


Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news